Alterity Therapeutics (PRNAD) Loans - Loss Allowance (2020)
Alterity Therapeutics (PRNAD) posted quarterly Loans - Loss Allowance of $112.9 million for Q4 2020, up 21.93% on a QoQ basis from $92.6 million in Q2 2020.
Alterity Therapeutics (PRNAD) Loans - Loss Allowance (2020) Analysis & Trends
Alterity Therapeutics (PRNAD) has reported Loans - Loss Allowance for 1 consecutive years, with $112.9 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Loans - Loss Allowance changed N/A year-over-year to $112.9 million; the TTM figure through Dec 2020 stood at $112.9 million (changed N/A YoY), while the FY2020 annual figure was $94.8 million, changed N/A from the prior year.
- Loans - Loss Allowance came in at $112.9 million for Q4 2020 at Alterity Therapeutics, up from $92.6 million in the prior quarter.
- The five-year high for Loans - Loss Allowance was $112.9 million in Q4 2020, with the low at $92.6 million in Q2 2020.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 112.87 Mn |
| Jun 30, 2020 | 92.57 Mn |